News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Rubin Marc
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/30/2023 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.11, valued at
$44.4k
|
|
| 01/24/2023 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 85,000 options to buy
@ $0.75, valued at
$63.8k
|
|
| 12/02/2022 |
3/A
| Rubin Marc (Incorrect Filing) has filed a Form 3/A on Medicine Man Technologies, Inc. |
| 11/07/2022 |
3
| Rubin Marc (10% Owner) has filed a Form 3 on Medicine Man Technologies, Inc. |
| 01/31/2022 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 85,000 options to buy
@ $3.19, valued at
$271.2k
|
|
| 01/25/2022 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 40,000 options to buy
@ $1.98, valued at
$79.2k
|
|
| 01/05/2022 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 65,000 options to buy
@ $1.18, valued at
$76.7k
|
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 33,000 options to buy
@ $9.14, valued at
$301.6k
|
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2020 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 30,000 options to buy
@ $2.86, valued at
$85.8k
|
|
| 04/03/2019 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 200,000 options to buy
@ $1.75, valued at
$350k
|
|
| 02/25/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2019 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Sold 18,500 shares
@ $1.0528, valued at
$19.5k
|
|
| 01/23/2019 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 180,000 options to buy
@ $1.16, valued at
$208.8k
|
|
| 01/18/2019 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 25,000 options to buy
@ $4.72, valued at
$118k
|
|
| 09/25/2018 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 400,000 shares
@ $0.25, valued at
$100k
Granted 400,000 warrants
@ $0.25, valued at
$100k
|
|
| 09/06/2018 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Exercised 6,000 shares
@ $0
Sold 11,900 shares
@ $6.5761, valued at
$78.3k
Exercised 6,000 options to buy
@ $0.89, valued at
$5.3k
|
|
| 09/04/2018 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Exercised 29,000 shares
@ $0
Sold 58,100 shares
@ $6.0811, valued at
$353.3k
Exercised 29,000 options to buy
@ $0.89, valued at
$25.8k
|
|
| 03/09/2018 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 170,000 options to buy
@ $0.97, valued at
$164.9k
|
|
| 01/24/2018 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 185,000 shares
@ $0 |
|
| 12/18/2017 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Granted 77,250 options to buy
@ $2.39, valued at
$184.6k
|
|
| 12/08/2017 |
4/A
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Bought 7,000 shares
@ $1.8531, valued at
$13k
|
|
| 12/08/2017 |
4
| Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC|
Txns:
| Bought 7,000 shares
@ $1.8531, valued at
$13k
|
|
| 11/16/2017 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Bought 25,000 shares
@ $0.98, valued at
$24.5k
|
|
| 03/02/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/02/2016 |
4/A
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 90,900 options to buy
@ $5.1, valued at
$463.6k
|
|
| 02/02/2016 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 79,100 options to buy
@ $5.1, valued at
$403.4k
|
|
| 01/21/2016 |
4
| Rubin Marc (Director) has filed a Form 4 on CURIS INC|
Txns:
| Granted 50,000 options to buy
@ $1.76, valued at
$88k
|
|
| 01/11/2016 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $3.25, valued at
$16.3k
|
|
| 12/16/2015 |
4
| Rubin Marc (Executive Chairman) has filed a Form 4 on TITAN PHARMACEUTICALS INC|
Txns:
| Granted 170,000 options to buy
@ $5.1, valued at
$867k
|
|
|
|
|